{"id":202173,"date":"2015-10-04T07:43:28","date_gmt":"2015-10-04T11:43:28","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/genetics-and-molecular-medicine.php"},"modified":"2015-10-04T07:43:28","modified_gmt":"2015-10-04T11:43:28","slug":"genetics-and-molecular-medicine","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/genetics-and-molecular-medicine.php","title":{"rendered":"Genetics and Molecular Medicine"},"content":{"rendered":"<p><p>    Genetics is the study of how biological traits and    characteristics are transmitted through generations and    families. Molecular medicine examines how illness and disease    occurs or can be prevented at the cellular or molecular level.    Both fields are experiencing exciting new developments in    research and in practical applications, as well as confronting    important legal, ethical andpolicy issues about their    use.  <\/p>\n<p>    The AMA is committed to providing extensive and up-to-date news    and information about these new fields of medicine and law,    whether discussing     genetic testing and     genetic discrimination, investigating     gene patenting, or explaining the Human Genome Project.  <\/p>\n<p>    Below are important announcements and personalized    medicine topics.  <\/p>\n<p>    AMA submits comments on FDA proposal to regulate    laboratory developed testing services and    procedures    On Feb. 2, 2015, the AMA submitted comments to the FDA expressing concern that    the agency's proposal to impose new regulatory requirements for    laboratory developed testing services and procedures would    hinder medical innovation and result in reduced patient access    to essential care. Laboratory developed testing services and    procedures are a critical part of the practice of medicine and    represent the majority of the advanced laboratory tests used in    patient care. In order to ensure physicians can continue to    provide patients with the best care possible and to innovate    and improve upon that care, the AMA urged the FDA to withdraw    it proposal, collaborate with other federal entities to    modernize existing laboratory oversight processes, conduct a    comprehensive environmental scan to identify key concerns, and    streamline and reform its regulation of manufacturers of    commercial diagnostic testing kits.  <\/p>\n<p>    AMA and others ask the FDA for notice and comment    rulemaking for LDT regulatory framework    On Nov. 18, 2014, the AMA and approximately 50 other groups    representing a broad range of stakeholders in genomic medicine    asked the FDA to withdraw its proposed guidance Framework for    Regulatory Oversight of Laboratory Developed Tests and instead    proceed using notice and comment rulemaking. Laboratory    developed testing (LDT) services are a vital area of medical    practice impacting the majority of patients across the country,    and wholesale change in oversight and regulation should be done    with full consideration of the clinical realities of health    care delivery. Notice and comment rulemaking will increase the    likelihood that the agency will be able to achieve regulatory    goals without jeopardizing the current delivery of testing    services to patients and the continued advancement in testing    and patient care. View the letter to the FDA.  <\/p>\n<p>    Guiding Principles on Personalized    Medicine    The AMA, in collaboration wth several medical specialty    societies,has developed legislative principles on personalized    medicine that guide its advocacy efforts. These principles are    rooted in the belief that physicians are integral to the    scientific inquiry and innovation processes that drive    personalized medicine, and that they must have the discretion    to utilizethe genetic tools that are most appropriate for    patient care. Since regulation of genetic tests is    integral to physician practice and patient care, the principle addressing oversight of    laboratory-developed tests has been further elaborated    upon.  <\/p>\n<p>        Education and research    Listing of several educational programs and initiatives in the    fields of genetics and molecular medicine.  <\/p>\n<p>        Family history    Describes the importance of a family medical history and    provides resources on how to collect information and generate a    simple pedigree.  <\/p>\n<p>        Current topics in genetics and medicine    Background information on the areas of applied genetics that    have the potential to affect medicine most profoundly.  <\/p>\n<p>        Genetics and policy issues    There is a vast body of evolving policy to guide physicians and    researchers through the maze of ethical, legal and social    issues surrounding genetics and molecular medicine. Highlights    of some of the most pressing policy topics are described here.    Topics include the stem cell research, genetic testing, genetic    discrimination, gene patenting, and use of human participants    in scientific research.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read more:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.ama-assn.org\/ama\/pub\/physician-resources\/medical-science\/genetics-molecular-medicine.page\" title=\"Genetics and Molecular Medicine\">Genetics and Molecular Medicine<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Genetics is the study of how biological traits and characteristics are transmitted through generations and families. Molecular medicine examines how illness and disease occurs or can be prevented at the cellular or molecular level. Both fields are experiencing exciting new developments in research and in practical applications, as well as confronting important legal, ethical andpolicy issues about their use.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/molecular-medicine\/genetics-and-molecular-medicine.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[26],"tags":[],"class_list":["post-202173","post","type-post","status-publish","format-standard","hentry","category-molecular-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/202173"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=202173"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/202173\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=202173"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=202173"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=202173"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}